Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Chronic Heart Failure

  Free Subscription


2 Am J Cardiol
4 Ann Thorac Surg
14 Cardiol Clin
3 Cardiovasc Res
2 Circ Heart Fail
3 Circ Res
1 Clin Cardiol
3 Eur Heart J
6 Eur J Heart Fail
16 Heart
4 Int J Cardiol
6 J Card Fail
3 J Mol Cell Cardiol
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Cardiol

  1. MIHALICK V, Wohlford G, Talasaz AH, Ho AJ, et al
    Patient Perceptions of Exertion and Dyspnea With Interleukin-1 Blockade in Patients With Recently Decompensated Systolic Heart Failure.
    Am J Cardiol. 2022 Apr 23. pii: S0002-9149(22)00331.
    PubMed         Abstract available

  2. DEL RIO-PERTUZ G, Benjanuwattra J, Juarez M, Triana AJ, et al
    Meta-Analysis Evaluating H2FPEF Score as a Prognostic Tool to Predict Mortality and Heart Failure-Related Hospitalization in Adults With Normal Left Ventricular Ejection Fraction and Dyspnea.
    Am J Cardiol. 2022 Apr 19. pii: S0002-9149(22)00356.

    Ann Thorac Surg

  3. PIENTA MJ, Wu X, Cascino TM, Brescia AA, et al
    Advancing Quality Metrics for Durable Left Ventricular Assist Device Implant: Analysis of the Society of Thoracic Surgeons Intermacs Database.
    Ann Thorac Surg. 2022;113:1544-1551.
    PubMed         Abstract available

  4. OPACIC D, Schramm R, Fox H, Gummert J, et al
    Replacement of the Right SynCardia Ventricle Due to Membrane Rupture.
    Ann Thorac Surg. 2022;113:e323-e325.
    PubMed         Abstract available

  5. BEDI R, Vu T, Bansal A
    Left Ventricular Assist Device Implantation to the Left Subclavian Artery With Distal Banding: A Novel Technique for Hostile Chest.
    Ann Thorac Surg. 2022;113:e381-e383.
    PubMed         Abstract available

    Hospital Outcomes in LVAD Therapy: Can We Benchmark Performance and Preserve Disruptive Innovation?
    Ann Thorac Surg. 2022;113:1551-1552.

    Cardiol Clin

  7. SALZANO A, Cassambai S, Yazaki Y, Israr MZ, et al
    The Gut Axis Involvement in Heart Failure: Focus on Trimethylamine N-oxide.
    Cardiol Clin. 2022;40:161-169.
    PubMed         Abstract available

  8. NAPOLI R, D'Assante R, Miniero M, Salzano A, et al
    Anabolic Deficiencies in Heart Failure: Ready for Prime Time?
    Cardiol Clin. 2022;40:149-159.
    PubMed         Abstract available

  9. PELLICORI P, Cleland JGF, Clark AL
    Chronic Obstructive Pulmonary Disease and Heart Failure: A Breathless Conspiracy.
    Cardiol Clin. 2022;40:171-182.
    PubMed         Abstract available

  10. CONIGLIO AC, Mentz RJ
    Sleep Breathing Disorders in Heart Failure.
    Cardiol Clin. 2022;40:183-189.
    PubMed         Abstract available

  11. DANZI S, Klein I
    Thyroid Abnormalities in Heart Failure.
    Cardiol Clin. 2022;40:139-147.
    PubMed         Abstract available

  12. VALENTOVA M, Anker SD, von Haehling S
    Cardiac Cachexia Revisited: The Role of Wasting in Heart Failure.
    Cardiol Clin. 2022;40:199-207.
    PubMed         Abstract available

  13. CARBONE S, Lavie CJ, Elagizi A, Arena R, et al
    The Impact of Obesity in Heart Failure.
    Cardiol Clin. 2022;40:209-218.
    PubMed         Abstract available

    The Cardiorenal Syndrome in Heart Failure.
    Cardiol Clin. 2022;40:219-235.
    PubMed         Abstract available

  15. DI PALO KE, Barone NJ
    Hypertension and Heart Failure: Prevention, Targets, and Treatment.
    Cardiol Clin. 2022;40:237-244.
    PubMed         Abstract available

  16. OBEIDAT M, Burgess M, Lip GYH
    Atrial Fibrillation in Heart Failure: Focus on Antithrombotic Management.
    Cardiol Clin. 2022;40:245-258.
    PubMed         Abstract available

  17. ROMITI GF, Recchia F, Zito A, Visioli G, et al
    Sex and Gender-Related Issues in Heart Failure.
    Cardiol Clin. 2022;40:259-268.
    PubMed         Abstract available

  18. DI PALO KE
    Psychological Disorders in Heart Failure.
    Cardiol Clin. 2022;40:269-276.
    PubMed         Abstract available

  19. CITTADINI A, Bossone E, Ventura HO
    Emerging Comorbidities in Heart Failure.
    Cardiol Clin. 2022;40:xi-xiv.

  20. MARRA AM, Benjamin N, Cittadini A, Bossone E, et al
    When Pulmonary Hypertension Complicates Heart Failure.
    Cardiol Clin. 2022;40:191-198.
    PubMed         Abstract available

    Cardiovasc Res

  21. MURPHY KA, Harsch BA, Healy CL, Joshi SS, et al
    Free fatty acid receptor 4 responds to endogenous fatty acids to protect the heart from pressure overload.
    Cardiovasc Res. 2022;118:1061-1073.
    PubMed         Abstract available

  22. YU JK, Liang JA, Franceschi WH, Huang Q, et al
    Assessment of arrhythmia mechanism and burden of the infarcted ventricles following remuscularization with pluripotent stem cell-derived cardiomyocyte patches using patient-derived models.
    Cardiovasc Res. 2022;118:1247-1261.
    PubMed         Abstract available

  23. GATICA D, Chiong M, Lavandero S, Klionsky DJ, et al
    The role of autophagy in cardiovascular pathology.
    Cardiovasc Res. 2022;118:934-950.
    PubMed         Abstract available

    Circ Heart Fail

  24. RETHY L, Vu TT, Shah NS, Carnethon MR, et al
    Blood Pressure and Glycemic Control Among Ambulatory US Adults With Heart Failure: National Health and Nutrition Examination Survey 2001 to 2018.
    Circ Heart Fail. 2022 Apr 28:101161CIRCHEARTFAILURE121009229.
    PubMed         Abstract available

  25. STERLING MR, Essien UR
    Implementing Equity: Improving Blood Pressure and Glycemic Control Among Adults With Heart Failure.
    Circ Heart Fail. 2022 Apr 28:101161CIRCHEARTFAILURE122009650.

    Circ Res

  26. Correction to: Heart Failure Subtypes and Cardiomyopathies in Women.
    Circ Res. 2022;130:e25.

  27. BRITTAIN EL, Hemnes AR
    Introduction to Review Series on Pulmonary Vascular Disease and Right Ventricular Heart Failure.
    Circ Res. 2022;130:1362-1364.

  28. YAO Y, Li F, Zhang M, Jin L, et al
    Targeting CaMKII-delta9 Ameliorates Cardiac Ischemia/Reperfusion Injury by Inhibiting Myocardial Inflammation.
    Circ Res. 2022;130:887-903.
    PubMed         Abstract available

    Clin Cardiol

  29. ROTH ME, Chinn ME, Dunn SP, Bilchick KC, et al
    Association of colchicine use for acute gout with clinical outcomes in acute decompensated heart failure.
    Clin Cardiol. 2022 Apr 28. doi: 10.1002/clc.23830.
    PubMed         Abstract available

    Eur Heart J

  30. MARON BA, Humbert M
    HFp2EF: heart failure with pulmonary dysfunction and preserved ejection fraction?
    Eur Heart J. 2022 Apr 25. pii: 6573597. doi: 10.1093.

  31. SHEN L, Jhund PS, Docherty KF, Vaduganathan M, et al
    Accelerated and personalized therapy for heart failure with reduced ejection fraction.
    Eur Heart J. 2022 Apr 25. pii: 6573857. doi: 10.1093.
    PubMed         Abstract available

  32. ECKHARDT CM, Balte PP, Barr RG, Bertoni AG, et al
    Lung function impairment and risk of incident heart failure: the NHLBI Pooled Cohorts Study.
    Eur Heart J. 2022 Apr 25. pii: 6573769. doi: 10.1093.
    PubMed         Abstract available

    Eur J Heart Fail

  33. REZA N, Butler J
    Assessing Health Status After Discharge for Decompensated Heart Failure: A Patient-Centered Priority.
    Eur J Heart Fail. 2022 Apr 28. doi: 10.1002/ejhf.2521.

  34. BORIANI G, Imberti JF, Vitolo M
    Dronedarone in the treatment of atrial fibrillation with concomitant heart failure and preserved or mildly reduced ejection fraction: closer to Ithaca after a long Odyssey?
    Eur J Heart Fail. 2022 Apr 28. doi: 10.1002/ejhf.2519.

  35. PELLICORI P, Cleland JG
    Heart failure: age is no excuse for complacency.
    Eur J Heart Fail. 2022 Apr 28. doi: 10.1002/ejhf.2517.

  36. CANNATA A, Bromage DI, McDonagh TA
    COVID and heart failure: the dark side of the moon.
    Eur J Heart Fail. 2022 Apr 28. doi: 10.1002/ejhf.2518.

  37. JIN X, Hung CL, Tay WT, Soon D, et al
    Epicardial Adipose Tissue related to Left Atrial and Ventricular Function in Heart Failure with Preserved (HFpEF) versus Reduced and Mildly Reduced Ejection Fraction (HFrEF/HFmrEF).
    Eur J Heart Fail. 2022 Apr 27. doi: 10.1002/ejhf.2513.
    PubMed         Abstract available

  38. XIE C
    Could angiotensin-converting enzyme inhibitors/angiotensin receptor blockers/angiotensin receptor-neprilysin inhibitor be used in heart failure patients with atrial fibrillation and low blood pressure?
    Eur J Heart Fail. 2022 Apr 27. doi: 10.1002/ejhf.2515.


  39. TUTAREL O, Baris L, Budts W, Gamal Abd-El Aziz M, et al
    Pregnancy outcomes in women with a systemic right ventricle and transposition of the great arteries results from the ESC-EORP Registry of Pregnancy and Cardiac disease (ROPAC).
    Heart. 2022;108:117-123.
    PubMed         Abstract available

  40. GULSIN GS, Graham-Brown MPM, Squire IB, Davies MJ, et al
    Benefits of sodium glucose cotransporter 2 inhibitors across the spectrum of cardiovascular diseases.
    Heart. 2022;108:16-21.
    PubMed         Abstract available

  41. AYTON SL, Gulsin GS, McCann GP, Moss AJ, et al
    Epicardial adipose tissue in obesity-related cardiac dysfunction.
    Heart. 2022;108:339-344.
    PubMed         Abstract available

  42. AKHTAR AM, Ghouri N, Chahal CAA, Patel R, et al
    Ramadan fasting: recommendations for patients with cardiovascular disease.
    Heart. 2022;108:258-265.
    PubMed         Abstract available

  43. GREER C, Troughton RW, Adamson PD, Harris SL, et al
    Preterm birth and cardiac function in adulthood.
    Heart. 2022;108:172-177.
    PubMed         Abstract available

  44. KAWAJI T, Ogawa H, Hamatani Y, Kato M, et al
    Association of inverted T wave during atrial fibrillation rhythm with subsequent cardiac events.
    Heart. 2021 May 26. pii: heartjnl-2021-319199. doi: 10.1136/heartjnl-2021-319199
    PubMed         Abstract available

  45. TAKAYA Y, Akagi T, Sakamoto I, Kanazawa H, et al
    Efficacy of treat-and-repair strategy for atrial septal defect with pulmonary arterial hypertension.
    Heart. 2022;108:382-387.
    PubMed         Abstract available

  46. AKYEA RK, Kontopantelis E, Kai J, Weng SF, et al
    Sex disparity in subsequent outcomes in survivors of coronary heart disease.
    Heart. 2021 Aug 24. pii: heartjnl-2021-319566. doi: 10.1136/heartjnl-2021-319566
    PubMed         Abstract available

  47. PATEL D, Kumar A, Moennich LA, Trulock K, et al
    Cardiac resynchronisation therapy in anthracycline-induced cardiomyopathy.
    Heart. 2022;108:274-278.
    PubMed         Abstract available

    Unusual presentation of cardiogenic shock in a young patient.
    Heart. 2022;108:211-242.

  49. HAYDOCK P, Camm AJ
    History and evolution of pacing and devices.
    Heart. 2022;108:794-799.
    PubMed         Abstract available

  50. MORITA S, Malik AH, Kuno T, Ando T, et al
    Analysis of outcome of 6-month readmissions after percutaneous left atrial appendage occlusion.
    Heart. 2022;108:606-612.
    PubMed         Abstract available

  51. SCHNABEL RB, Wallenhorst C, Engler D, Blankenberg S, et al
    Refined atrial fibrillation screening and cost-effectiveness in the German population.
    Heart. 2021 Aug 10. pii: heartjnl-2020-318882. doi: 10.1136/heartjnl-2020-318882
    PubMed         Abstract available

  52. PHILLIPS K, Subramanian A, Thomas GN, Khan N, et al
    Trends in the pharmacological management of atrial fibrillation in UK general practice 2008-2018.
    Heart. 2021 Jul 5. pii: heartjnl-2021-319338. doi: 10.1136/heartjnl-2021-319338.
    PubMed         Abstract available

  53. MUDIGONDA P, Berardi C, Chetram V, Barac A, et al
    Implications of cancer prior to and after heart transplantation.
    Heart. 2021 Jul 1. pii: heartjnl-2020-318139. doi: 10.1136/heartjnl-2020-318139.
    PubMed         Abstract available

  54. BHAGRA SK, Pettit S, Parameshwar J
    Implantable left ventricular assist device: indications, eligibility and current outcomes.
    Heart. 2022;108:233-241.

    Int J Cardiol

  55. YU X
    Heart failure with improved ejection fraction: The current and future in Asian populations.
    Int J Cardiol. 2022 Apr 26. pii: S0167-5273(22)00579.

  56. LI L, Zhang Z, Xiong Y, Hu Z, et al
    Prediction of hospital mortality in mechanically ventilated patients with congestive heart failure using machine learning approaches.
    Int J Cardiol. 2022 Apr 25. pii: S0167-5273(22)00581.
    PubMed         Abstract available

  57. CIARDULLO S, Cannistraci R, Mazzetti S, Mortara A, et al
    Twenty-year trends in heart failure among U.S. adults, 1999-2018: The growing impact of obesity and diabetes.
    Int J Cardiol. 2022 Apr 26. pii: S0167-5273(22)00578.
    PubMed         Abstract available

  58. CIEPLUCHA A, Trojnarska O, Rajewska-Tabor J, Bartczak-Rutkowska A, et al
    Left, but not right, ventricular status determines heart failure in adults with Ebstein anomaly - A case-control study based on magnetic resonance.
    Int J Cardiol. 2022 Apr 25. pii: S0167-5273(22)00585.
    PubMed         Abstract available

    J Card Fail

  59. MG P, T W, Ac A, A B, et al
    Baseline Quality of Life of Caregivers of Patients with Heart Failure Prior to Advanced Therapies: Findings from the Sustaining Quality of Life of the Aged: Transplant or Mechanical Support (SUSTAIN-IT) study.
    J Card Fail. 2022 Apr 22. pii: S1071-9164(22)00491.
    PubMed         Abstract available

  60. RAO VN, Andrews J, Applefeld WN, Gray JM, et al
    Quantitative Blood Volume Analysis and Hemodynamic Measures of Vascular Compliance in Patients with Worsening Heart Failure: BVA and Hemodynamic Profiles in Worsening HF.
    J Card Fail. 2022 Apr 25. pii: S1071-9164(22)00494.
    PubMed         Abstract available

  61. DENG LR, Matlock DD, Bekelman DB
    Preferred Role in Healthcare Decision-Making Over Time among Patients with Heart Failure: My Decision, Or My Doctor's Decision?
    J Card Fail. 2022 Apr 22. pii: S1071-9164(22)00493.
    PubMed         Abstract available

  62. HERNANDEZ AF, Albert NM, Allen LA, Ahmed R, et al
    Multiple cArdiac seNsors for mAnaGEment of Heart Failure (MANAGE-HF) - Phase I Evaluation of the Integration and Safety of the HeartLogic Multisensor Algorithm in Patients With Heart Failure.
    J Card Fail. 2022 Apr 20. pii: S1071-9164(22)00483.
    PubMed         Abstract available

  63. ZHUO M, Kim SC, Patorno E, Paik JM, et al
    Risk of hospitalization for heart failure in patients with hyperkalemia treated with sodium zirconium cyclosilicate versus patiromer.
    J Card Fail. 2022 Apr 22. pii: S1071-9164(22)00492.
    PubMed         Abstract available

  64. YOO EJ, Hahn VS
    Tackling the Heterogeneity of Heart Failure with Preserved Ejection Fraction using Proteomic Profiling.
    J Card Fail. 2022 Apr 22. pii: S1071-9164(22)00485.

    J Mol Cell Cardiol

  65. SEDEJ S, Abdellatif M
    Metabolic therapy for managing heart failure with preserved ejection fraction.
    J Mol Cell Cardiol. 2022;168:68-69.

  66. ZHAO Y, Godier-Furnemont A, Bax NAM, Bouten CVC, et al
    Changes in extracellular matrix in failing human non-ischemic and ischemic hearts with mechanical unloading.
    J Mol Cell Cardiol. 2022;166:137-151.
    PubMed         Abstract available

  67. KANASSATEGA RS, Bunch TA, Lepak VC, Wang C, et al
    Human cardiac myosin-binding protein C phosphorylation- and mutation-dependent structural dynamics monitored by time-resolved FRET.
    J Mol Cell Cardiol. 2022;166:116-126.
    PubMed         Abstract available

    PLoS One

  68. BANERAS J, Pariggiano I, Rodenas-Alesina E, Oristrell G, et al
    Optimal opportunistic screening of atrial fibrillation using pulse palpation in cardiology outpatient clinics: Who and how.
    PLoS One. 2022;17:e0266955.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.